Literature DB >> 2454326

Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control.

D S Staskin1, Y Vardi, M B Siroky.   

Abstract

A retrospective urodynamic study of 50 parkinsonian patients was done to determine the incidence and causes of post-prostatectomy incontinence. At presentation 22 per cent of the patients were incontinent. In 36 patients who underwent transurethral prostatectomy the incontinence rate was 17 per cent preoperatively and 28 per cent postoperatively. There was a clear association between normal voluntary sphincter control and urinary continence. After transurethral prostatectomy 5 of 6 patients continent preoperatively (83 per cent) who had abnormal sphincter control became incontinent compared to 1 of 24 (4.2 per cent) who had normal sphincter control. We conclude that the major risk of incontinence following prostatectomy in the parkinsonian patient is associated with lack of voluntary sphincter control.

Entities:  

Mesh:

Year:  1988        PMID: 2454326     DOI: 10.1016/s0022-5347(17)41501-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Neurogenic Causes of Detrusor Underactivity.

Authors:  Brian T Kadow; Pradeep Tyagi; Christopher J Chermansky
Journal:  Curr Bladder Dysfunct Rep       Date:  2015-09-15

Review 2.  Assessment and therapy for voiding dysfunction after prostatectomy.

Authors:  Rodney A Appell
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

Review 3.  Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms.

Authors:  Bilal Chughtai; Vannita Simma-Chiang; Steven A Kaplan
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

Review 4.  A review of lower urinary tract symptoms in patients with Parkinson's disease.

Authors:  Anand V Badri; Rajveer S Purohit; Jason Skenazy; Jeffrey P Weiss; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

5.  Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease.

Authors:  Cristiano M Gomes; Zein M Sammour; Jose de Bessa Junior; Egberto R Barbosa; Roberto I Lopes; Flávio S Sallem; Flavio E Trigo-Rocha; Homero Bruschini; Victor W Nitti; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

Review 6.  Treatment Options for Urogenital Dysfunction in Parkinson's Disease.

Authors:  Amit Batla; Natalie Tayim; Mahreen Pakzad; Jalesh N Panicker
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.